Viewing Abstracts
View hundreds of top-tier abstracts exploring the most cutting-edge advancements in the region.
Explore Abstracts Onsite
Poster Hall
Browse posters at your own pace throughout the hall during open hours.
Location: Houston 4-7, 2nd Floor
Open Hours
Friday, February 13 | 09:30 - 17:00
Saturday, February 14 | 09:30 - 17:00
Sunday, February 15 | 09:30 - 11:00
Poster Sessions
Researchers will present their findings and be available to answer questions or discuss their work.
Friday, February 13 | 13:00 - 14:30
Saturday, February 14 | 13:30 - 15:00
Guided Poster Tours
Hear discussion on a select group of high-scoring abstracts dealing with defined topics.
Friday, February 13 | 13:00 - 14:30
Saturday, February 14 | 13:30 - 15:00
2026 Poster Schedules
Friday, February 13
AI, Technology, Telemedicine
- Artificial Intelligence (AI) and Machine Learning — Abstracts 1-3
- Technology — Abstracts 4-8
Allied Healthcare, Quality of Life, Palliative Care, Patient Perspectives
- Allied Healthcare: Physical Therapy, Speech Therapy, Rehabilitation — Abstracts 10-11
- Patient Perspectives — Abstract 12
Atypical and Other Parkinsonisms
- Epidemiology, Phenomenology, Clinical Assessment, Rating Scales — Abstracts 15-18
- Etiology — Abstract 19
- Neuroimaging — Abstract 20
- MSA, PSP, CBS: Other — Abstracts 21-24
- Parkinsonism: Other — Abstracts 25-36
Dystonia
- Disease Mechanisms / Neuroimaging / Neurophysiology — Abstract 37
- Epidemiology, phenomenology, clinical assessment, rating scales — Abstract 38
- Genetics — Abstract 39
- Medical Therapy / Surgical Therapy — Abstracts 40-44
- Other — Abstract 45
Education, History, Disparities, Other Topics
- Disparities — Abstracts 46-49
- Education in Movement Disorders — Abstracts 50-51
- History of Movement Disorders — Abstract 52
- Other — Abstracts 53-54
Functional, Drug-Induced, Autoimmune Movement Disorders
- Autoimmune Movement Disorders — Abstracts 55-58
- Drug-Induced Movement Disorders — Abstract 60
- Functional Movement Disorders / Psychogenic Movement Disorders — Abstracts 61-63
Hyperkinetic Movement Disorders (Non-Dystonia)
- Ataxia — Abstracts 64-73, 111
- Choreas (Non-Huntington’s Disease) — Abstracts 74-78
- Huntington’s Disease — Abstracts 80-85
- Myoclonus / Tics / Stereotypies — Abstracts 87-90
- Tremor — Abstracts 91-92
- Other — Abstracts 93-96
Parkinson's Disease
- Biomarkers (Non-Neuroimaging) — Abstract 99
- Clinical Trials — Abstracts 100-110
Saturday, February 14
Parkinson's Disease
- Epidemiology, Phenomenology, Clinical Assessment, Rating Scales — Abstracts 120-146, 236
- Cognition / Psychiatirc Manifestations / Lewy Body Dementia — Abstracts 147-155
- Disease Mechanisms — Abstract 156
- Genetics — Abstracts 157-164
- Neuroimaging — Abstracts 165-172
- Non-Motor Symptoms (Non-Cogntivie / Non-Psychiatric) — Abstracts 173-178
- Pathophysiology / Molecular Mechanisms of Disease — Abstracts 179-181
- Pharmacology and Medical Management — Abstracts 182-190
- Surgical Therapy — Abstracts 191-199, 237
- Other — Abstracts 200-211
Pediatric, Rare Inherited and Neurometabolic Disorders, and Paroxysmal Movement Disorders
- Paroxysmal Movement Disorders — Abstracts 212
- Pediatric Movement Disorders — Abstracts 213-215
- Rare Inherited and Neurometabolic Movement Disorders — Abstracts 216-235
2026 Guided Poster Tours
Friday, February 13
Open AllClose All
Guided Poster Tour Group 1: AI, Allied Healthcare, and Education
|
Friday, February 13 |
|||
| Abstract Number: | Abstract Title: | Abstract Category: | Abstract Subcategory: |
| 1 | PD&Me: Exploring Quality of Life, Access to Care, and Patient Attitudes Toward Technology-Aided Solutions in Canada | AI, Technology, Telemedicine | Artificial Intelligence (AI) and Machine Learning |
| 5 | Real-world Validation of the Electrode Identifier for Electrophysiology-guided DBS Programming | AI, Technology, Telemedicine | Technology |
| 6 | Development of a Patient-Centric Botulinum Toxin Response Scale (BTRS) Through Qualitative Analysis | AI, Technology, Telemedicine | Technology |
| 7 | AI-Integrated Exoskeletons in Neurorehabilitation: A Paradigm Shift in Motor Recovery for Parkinson's Disease, Multiple Sclerosis, and Paraplegia | AI, Technology, Telemedicine | Technology |
| 8 | Spatiotemporal Gait Impairments and Clinical Correlates in Hereditary Spastic Paraplegias: First Data Analysis from the iAXON-Brazil Network | AI, Technology, Telemedicine | Technology |
| 12 | A Quality Analysis of Online Facebook Videos as an Information Source for the Application of High Intensity Focused Ultrasound in Essential Tremor: Media-Based Cross-Sectional Study | Allied Healthcare, Quality of Life, Palliative Care, Patient Perspectives | Patient Perspectives |
| 47 | Improving Recruitment of Underrepresented Groups in the PD GENEration Study | Education, History, Disparities, Other Topics | Disparities |
| 48 | Environmental Risk Factors for Lewy Body Dementia: A Pilot Study for Sex-Specific Risk | Education, History, Disparities, Other Topics | Disparities |
| 50 | Impact of a Genetic Counseling Workshop on Specialists’ Confidence in Returning Parkinson’s Disease Genetic Results | Education, History, Disparities, Other Topics | Education in Movement Disorders |
| 51 | Brain Health Ambassadors Program: A Pilot Initiative to Improve Multigenerational Brain Health Literacy through Youth Programming | Education, History, Disparities, Other Topics | Education in Movement Disorders |
| 54 | Early outcomes and safety of MR-guided focused ultrasound VIM thalamotomy for tremor control: first Brazilian clinical experience | Education, History, Disparities, Other Topics | Other |
Guided Poster Tour Group 2: Atypical Parkinsonisms and Hyperkinetic Movement Disorders Including Dystonia
| Friday, February 13 13:00 - 14:30 Leader: Nicolas Labaure |
|||
| Abstract Number: | Abstract Title: | Abstract Category: | Abstract Subcategory: |
| 19 | Description possible enviromental exposure in AMS Latin American Population | Atypical and Other Parkinsonisms | MSA, PSP, CBS: Etiology |
| 22 | Diagnostic Gaps in Atypical Parkinsonism in Latin America: Results from a Regional Survey of Physicians Involved in Patient Care | Atypical and Other Parkinsonisms | MSA, PSP, CBS: Other |
| 23 | Validating Capsule-Based Training for Atypical Parkinsonism with AI in Latin America: Insights from the LARGE-PD Consortium | Atypical and Other Parkinsonisms | MSA, PSP, CBS: Other |
| 24 | Post-Apneic Blunting of Chronotropic Response During Nocturnal Sleep in MSA: Diagnostic value and therapeutic intervention | Atypical and Other Parkinsonisms | MSA, PSP, CBS: Other |
| 28 | Leveraging markerless video-based gait analysis to diagnose NPH. | Atypical and Other Parkinsonisms | Parkinsonism: Other |
| 33 | Teaching the Eyes to See: A Structured Routine for Eye Movement Examination in Parkinsonian Disorders | Atypical and Other Parkinsonisms | Parkinsonism: Other |
| 37 | Modeling Laryngeal Dystonia through Spectral Analyses of Vocalizations in a Dystonia Mouse Model | Dystonia | Dystonia: Disease Mechanisms / Neuroimaging / Neurophysiology |
| 44 | DEEP BRAIN STIMULATION FOR DYSTONIA: GLOBUS PALLIDUS VS. SUBTHALAMIC NUCLEUS, BETTER RESPONSE AND EASIER TO PROGRAM IN THE SUBTHALAMIC NUCLEUS | Dystonia | Dystonia: Medical Therapy / Surgical Therapy |
| 63 | Functional Movement Disorders (FMD) Misdiagnosis: A Systematic Review | Functional, Drug-Induced, Autoimmune Movement Disorders | Functional Movement Disorders / Psychogenic Movement Disorders |
| 64 | Fronto-cerebellar Circuit Underlying Impulsivity and Compulsivity: A Lesion Network Mapping Study | Hyperkinetic Movement Disorders (Non-Dystonia) | Ataxia |
| 70 | Characterization of Peripheral Neuropathies in Spinocerebellar Ataxias: A Peruvian Cohort Study | Hyperkinetic Movement Disorders (Non-Dystonia) | Ataxia |
| 71 | Cerebellar Ataxia due to chronic toluene intoxication: a case report | Hyperkinetic Movement Disorders (Non-Dystonia) | Ataxia |
| 80 | Assessment of Functional Impairment in Individuals with Huntington’s Disease Chorea: a Modified Delphi Consensus Study | Hyperkinetic Movement Disorders (Non-Dystonia) | Huntington’s Disease |
| 82 | Revisiting the Link Between Huntington’s Disease and Cancer: Evidence from the Enroll-HD dataset | Hyperkinetic Movement Disorders (Non-Dystonia) | Huntington’s Disease |
Guided Poster Tour Group 3: Parkinson's Disease Biomarkers and Clinical Trials
| Friday, February 13 13:00 - 14:30 Leader: Santiago Perez Lloret |
|||
| Abstract Number: | Abstract Title: | Abstract Category: | Abstract Subcategory: |
| 99 | Exercise-Induced Changes in Circulating Biomarkers in Parkinson’s Disease: Systematic Review and Meta-analysis | Parkinson's Disease | Parkinson's Disease: Biomarkers (Non-Neuroimaging) |
| 100 | Electrosonic stimulation for the treatment of motor symptoms in parkinson’s disease: motion analysis assessments | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
| 102 | Complete Elimination of “Off” Time in People With Advanced Parkinson’s Disease Treated With Foslevodopa/Foscarbidopa: Post Hoc Analysis of Two Phase 3 Trials | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
| 103 | Qigong exercise improves UPDRS and freezing of gait in patients with PD | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
| 104 | Neural Correlates of the Improvement of Motor and Non-Motor Symptoms in Parkinson’s Disease Following a Combined Digital and Levodopa Therapy | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
| 105 | Hybrid Treatment with the DopApp Digital Application Improves MDS-UPDRS Across Parkinson’s Disease Stages: A Double-Blind, Placebo-Controlled Trial with Subgroup Analysis | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
| 107 | Digital Sensorimotor Training Enhances Thalamocortical Connectivity and Motor Function in Parkinson’s Disease: Evidence from Healthy and Affected Populations | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
| 110 | The Effects of Perceived Treatment on Non-Motor Symptoms of Parkinson’s Disease in a Randomized, Double-Blind, Placebo-Controlled Trial | Parkinson's Disease | Parkinson's Disease: Clinical Trials |
Saturday, February 14
Open AllClose All
Guided Poster Tour Group 4: PD: Genetics and Neuroimaging
| Saturday, February 14 13:30 - 15:00 Leader: Shannon Chiu |
|||
| Abstract Number: | Abstract Title: | Abstract Category: | Abstract Subcategory: |
| 157 | ASSESSING THE ROLE OF AFG3L2 PATHOGENIC VARIANTS IN PARKINSON'S DISEASE | Parkinson's Disease | Parkinson's Disease: Genetics |
| 159 | Exploratory genome-wide association study of Levodopa-Induced Dyskinesias in Latinos | Parkinson's Disease | Parkinson's Disease: Genetics |
| 160 | Elucidating dual carrier dynamics in GBA-LRRK2 using clinico-pathological correlates | Parkinson's Disease | Parkinson's Disease: Genetics |
| 161 | Genetic characterization of Parkinson’s Disease in a Chilean cohort | Parkinson's Disease | Parkinson's Disease: Genetics |
| 162 | Differences in the frequency of non-motor symptoms between genetically-confirmed and idiopathic Parkinson's disease in a sample from the southwestern of Colombia. | Parkinson's Disease | Parkinson's Disease: Genetics |
| 164 | Genetic Profile of Early-Onset Parkinson's Disease in Latin America: A Systematic Review | Parkinson's Disease | Parkinson's Disease: Genetics |
| 165 | Cerebellar Compensation and Functional Connectivity Shifts in Parkinson’s Disease | Parkinson's Disease | Parkinson's Disease: Neuroimaging |
| 166 | Connectivity-Based Parcellation of the Subthalamic Nucleus Using Probabilistic Tractography | Parkinson's Disease | Parkinson's Disease: Neuroimaging |
| 167 | Applying Machine Learning with Neuroimaging Biomarkers to Detect Parkinson’s Disease and Cognitive Impairment | Parkinson's Disease | Parkinson's Disease: Neuroimaging |
| 168 | Impact of APOE4 on Cortical Morphology and Cognition in Parkinson’s Disease: A PPMI Study | Parkinson's Disease | Parkinson's Disease: Neuroimaging |
| 169 | Connectivity Differences within the Cerebello-Thalamo-Cortical Circuit in Parkinson’s Disease Patients with Different Tremor Phenotypes | Parkinson's Disease | Parkinson's Disease: Neuroimaging |
| 170 | Temporal patterns of neural firing in human subthalamic nucleus during speech production compared to non-speech orofacial movement | Parkinson's Disease | Parkinson's Disease: Neuroimaging |
| 199 | Long-Term Metabolic Network Modulation After STN-DBS in Parkinson’s Disease: A Longitudinal ^18F-FDG PET Study | Parkinson's Disease | Parkinson's Disease: Surgical Therapy |
| 225 | FXTAS and the FMR1 premutation phenotypic spectrum in Latin America: A scoping review | Pediatric, Rare Inherited and Neurometabolic Disorders, and Paroxysmal Movement Disorders | Rare Inherited and Neurometabolic Movement Disorders |
Guided Poster Tour Group 5: PD: Epidemiology & Non-Motor Symptoms, Pharmacology
| Saturday, February 14 13:30 - 15:00 Leader: Malco Rossi |
|||
| Abstract Number: | Abstract Title: | Abstract Category: | Abstract Subcategory: |
| 121 | Diabetes and Parkinson’s Disease: A Hazard Ratio Meta-Analysis with Global and Sex-Specific Projections to 2050 | Parkinson's Disease | Parkinson’s Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales |
| 122 | Bidirectional Association Between Parkinson’s Disease and Skin Cancer: A Systematic Review and Meta-Analysis | Parkinson's Disease | Parkinson’s Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales |
| 130 | A Novel Clinic for Individuals At-Risk for Parkinson's Disease | Parkinson's Disease | Parkinson’s Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales |
| 132 | Towards Precision Prognosis in Parkinson’s Disease: Multimodal Predictors of Clinical Milestones from the PPMI Study | Parkinson's Disease | Parkinson’s Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales |
| 135 | Forecasting the burden of Parkinson’s disease in Mexico (2014–2025): A nationwide incidence analysis using the Prophet model | Parkinson's Disease | Parkinson’s Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales |
| 142 | Clinical and environmental features of Parkinson’s disease in El Salvador: findings from LARGE-PD case-control study | Parkinson's Disease | Parkinson’s Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales |
| 148 | Neuropsychiatric and Imaging Correlates to Impulse Control in Parkinson Disease (PD) Patients | Parkinson's Disease | Parkinson's Disease: Cognition / Psychiatirc Manifestations / Lewy Body Dementia |
| 150 | Clinical impact of α-synuclein oligomers in dementia with Lewy bodies. | Parkinson's Disease | Parkinson's Disease: Cognition / Psychiatirc Manifestations / Lewy Body Dementia |
| 153 | The influence of long-term amantadine therapy on MoCA Scores in people living with Parkinson's Disease | Parkinson's Disease | Parkinson's Disease: Cognition / Psychiatirc Manifestations / Lewy Body Dementia |
| 154 | Network Proteomics Identifies Regional Pathophysiological Signatures in the Lewy Body Dementia Brain | Parkinson's Disease | Parkinson's Disease: Cognition / Psychiatirc Manifestations / Lewy Body Dementia |
| 155 | Clinical and Inflammatory Correlates of Psychosis in Parkinson’s Disease: A Preliminary Cross-Sectional Study | Parkinson's Disease | Parkinson's Disease: Cognition / Psychiatirc Manifestations / Lewy Body Dementia |
| 184 | GLP-1 Receptor Agonists for Motor and Non-Motor Outcomes in Parkinson’s Disease: A Systematic Review and Meta-Analysis | Parkinson's Disease | Parkinson's Disease: Pharmacology and Medical Management |
| 190 | Reducing Inpatient Medication Errors in Parkinson’s Disease: A Multidisciplinary Approach | Parkinson's Disease | Parkinson's Disease: Pharmacology and Medical Management |
| 201 | Effects of Intravenous Allogeneic Mesenchymal Stem Cell Infusions on Neurodegeneration in Parkinson’s Disease | Parkinson's Disease | Parkinson's Disease: Other |
| 207 | Autologous iPSC-Derived Midbrain Dopaminergic Progenitors (BXT-110) Demonstrate Reproducible Efficacy and Safety in Preclinical Models of Parkinson’s Disease | Parkinson's Disease | Parkinson's Disease: Other |
| 235 | Preliminary report of home-based tDCS for non-motor symptoms of Huntington’s disease: an open-label study | Pediatric, Rare Inherited and Neurometabolic Disorders, and Paroxysmal Movement Disorders | Rare Inherited and Neurometabolic Movement Disorders |
Publication
All accepted PAS Congress abstracts will be published in a digital supplement to the Movement Disorders Clinical Practice journal, online edition.
If you have questions regarding where to find and view abstracts, contact the MDS International Secretariat at pascongress@movementdisorders.org.